首页|期刊导航|Cancer Innovation|Global,Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer Risk

Global,Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer RiskOA

中文摘要

Background:Immune-mediated inflammatory disease(IMID)and cancer share underlying mechanisms.We aimed to comprehensively evaluate the associations between IMIDs and cancers from global,population and genetic perspectives.Methods:A triangulation framework was employed to assess the association between IMIDs and cancers,using the Global Burden of Disease Study(2012-2021)to analyse six IMIDs and 33 cancers.The UK Biobank(UKBB)prospective cohort was subsequently used to validate these associations,with hazard ratios(HRs)and 95%confidence intervals(CIs)estimated by Cox proportional hazards models.Causal inference based on genetic instruments was performed in the FinnGen and UKBB to assess the potential causal effects between IMIDs and cancers.Results:IMIDs were positively associated with the occurrence of cancers from a global perspective.Moreover,170 specific IMID-cancer pairs revealed statistically significant associations.A total of 20 pairs of specific IMID-cancer associations were further confirmed in the UKBB cohort.Among these,the five most pronounced associations included atopic dermatitis with Hodgkin lymphoma(HR=12.56,95%CI:1.76-89.59),with ovarian cancer(HR=5.65,95%CI:1.41-22.65)and with non-Hodgkin lymphoma(HR=5.11,95%CI:1.91-13.63);rheumatoid arthritis with Hodgkin lymphoma(HR=3.85,95%CI:1.11-13.32);and psoriasis with Hodgkin lymphoma(HR=3.43,95%CI:1.69-6.96).Additionally,a positive causal association between rheumatoid arthritis and Hodgkin lymphoma(inverse variance weighted OR=1.31,95%CI:1.10-1.57)was observed.Conclusions:This study provides comprehensive evidence of the relationships between IMIDs and cancers from global,population and genetic perspectives and identifies 20 pairs of specific IMID-cancer associations,thereby contributing to advancements in cancer prevention and control.

Xuesi Dong;Jiaxin Xie;Zilin Luo;Hao Hong;Chenran Wang;Yadi Zheng;Xiaoyue Shi;Zeming Guo;Xiaolu Chen;Yongjie Xu;Wei Cao;Fei Wang;Dong Hang;Sipeng Shen;Fengwei Tan;Ni Li

Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Biostatistics,School of Public Health,Nanjing Medical University,Nanjing,Jiangsu,China Jiangsu Key Lab of Cancer Biomarkers,Prevention and Treatment,Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing Medical University,Nanjing,Jiangsu,China Changzhou Institute for Advanced Study of Public Health,Nanjing Medical University,Changzhou,Jiangsu,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Epidemiology and Biostatistics,Jiangsu Key Lab of Cancer Biomarkers,Prevention and Treatment,Collaborative Innovation Center for Cancer Personalized Medicine,School of Public Health,Nanjing Medical University,Nanjing,Jiangsu,ChinaDepartment of Biostatistics,School of Public Health,Nanjing Medical University,Nanjing,Jiangsu,China Jiangsu Key Lab of Cancer Biomarkers,Prevention and Treatment,Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing Medical University,Nanjing,Jiangsu,China Changzhou Institute for Advanced Study of Public Health,Nanjing Medical University,Changzhou,Jiangsu,ChinaDepartment of Thoracic Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Department of Epidemiology and Biostatistics,Jiangsu Key Lab of Cancer Biomarkers,Prevention and Treatment,Collaborative Innovation Center for Cancer Personalized Medicine,School of Public Health,Nanjing Medical University,Nanjing,Jiangsu,China

医药卫生

cancerepidemiologyevidence triangulationimmune-mediated inflammatory diseases

《Cancer Innovation》 2026 (1)

P.64-73,10

National Natural Science Foundation of China,Grant/Award Numbers:82404340,82273722,82373685,82204143CAMS Innovation Fund for Medical Science,Grant/Award Number:2021-I2M-1-067Open Research Fund Programme of Changzhou Institute for Advanced Study of Public Health,Nanjing Medical University,Grant/Award Number:CPHM202301。

10.1002/cai2.70048

评论